병원 | 교수 |
---|
2006 ~ 2012 | 고려대대학원 내과학과 박사 |
---|
2023 ~ 현재 | 경희대학교병원 제8중환자실(내과계) 실장 |
---|---|
~ 현재 | 경희대학교병원 QI 3차장 |
2020 ~ 현재 | 경희대학교병원 호흡기알레르기내과 부교수 |
~ | 경희대학교병원 호흡기내과 진료과장 |
2016 ~ 2020 | 경희대학교병원 호흡기알레르기내과 조교수 |
2013 ~ 2016 | 한전의료재단 한전병원 호흡기내과 과장 |
2012 ~ 2013 | 고대안암병원 호흡기내과 임상조교수 |
2010 ~ 2012 | 고대안암병원 호흡기내과 임상강사 |
2021 ~ 현재 | 대한 폐암학회 평의원 |
---|---|
2021 ~ 현재 | European Society for Medical Oncology (ESMO) member |
2020 ~ 현재 | Asian Pacific Society of Respirology (APSR) member |
2020 ~ 현재 | 대한 결핵 및 호흡기학회 기획위원 |
2019 ~ 현재 | 대한 내과학회 교육위원 |
2016 ~ 현재 | International Association for the Study of Lung Cancer (IASLC) Member |
2016.11 | 호흡기학 Manual |
---|---|
2020.08 | 호흡기학 manual : 호흡기내과 전공의를 위한 실용적인 치료 지침서 |
2021 | 고의의학상 |
---|---|
2021 | KALC International Conference Best Presentation Award |
2018 | 대한결핵 및 호흡기학회 우수초록상 |
2018 | 대한폐암학회 학술상 |
2022. | Capmatinib in MET Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma with Extensive Central Nervous System Metastasis |
---|---|
2022. | High Tumor Mutation Burden Is Associated with Poor Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy |
2022. | A Study on the Perception of Concurrent Use of Western and Korean Medicine Care and Integrated Medical Service in Korea - Targeting tertiary hospital users |
2022. | Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG) |
2021. | Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy |
2021. | Metataxonomic investigation of the microbial community in the trachea and oropharynx of healthy controls and diabetic patients using endotracheal tubes |
2021. | Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study |
2021. | Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG) |
2021. | Angiogenic activities are increased via upregulation of HIF-1α expression in gefitinib-resistant non- small cell lung carcinoma cells |
2021. | Detection of intracellular lamellar bodies as a screening marker for fibrotic lesions |
2021. | Repeated intratracheal instillation of zinc oxide nanoparticles induced pulmonary damage and a systemic inflammatory response in cynomolgus monkeys |
2021. | Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum-based doublet chemotherapy and immunotherapy (SPACE study) |
2021. | Effectiveness and safety of herbal medicine for cancer-related fatigue in lung cancer survivors: A systematic review and meta- analysis |
2020. | Coexisting active pulmonary tuberculosis in tuberculous spondylitis: the prevalence and the role of chest CT |
2020. | KCP10043F Represses the Proliferation of Human Non-Small Cell Lung Cancer Cells by Caspase- Mediated Apoptosis via STAT3 Inactivation |
2020. | The Efficacy and Safety of Acupuncture for Preventing Radiation Pneumonitis in Patients With Lung Cancer: A Prospective, Single-Blinded, Randomized Pilot Proof-of-Principle Study |
2020. | Evaluating the effect of a smartphone app-based self- management program for people with COPD: A randomized controlled trial |
2020. | Primary Resistance to Immune Checkpoint Blockade in an STK11/TP53/KRAS- Mutant Lung Adenocarcinoma with High PD-L1 Expression |
2020. | Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study |
2020. | High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy |
2020. | Diagnostic and Predictive Values of 18 F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma |
2020. | Formation of lamellar body-like structure may be an initiator of didecyldimethylammonium chloride-induced toxic response |
2020. | The efficacy and safety of Kyung- Ok-Ko on cancer-related fatigue in lung cancer patients: Study protocol for a randomized, patients-assessor blind, placebo-controlled, parallel- group, single-center trial. |
2020. | Radiosensitizing effect of combined triptolide and irradiation treatment in lung cancer cell lines |
2019. | Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study |
2019. | Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study |
2019. | Hyaluronic acid-induced diffuse alveolar hemorrhage: unknown complication induced by a well- known injectable agent |
2019. | Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma |
2019. | Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis |
NANOG predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy | |
Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy | |
Reactive oxygen species modulator 1 (Romo1) as a diagnostic marker for lung cancer-related malignant effusion | |
NANOG predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy | |
Prognostic value of plasma soluble ST2 concentration in respiratory failure patients | |
Deep vein thrombosis, pulmonary thromboembolism, aortic valve vegetation, and stroke in a patient with advanced lung adenocarcinoma: A case of Trousseau’s syndrome | |
Pemetrexed continuation maintenance versus conventional platinum-based doublet chemotherapy in EGFR-negative lung adenocarcinoma: retrospective analysis | |
Clinical manifestations of subjects with COPD depending on comorbid depression and risk factors associated with depression | |
A case of diffuse alveolar hemorrhage after illegal vaginal injection of hyaluronic acid | |
TAS-116, a novel heat shock protein 90 inhibitor, enhances radiosensitivity of non-small cell lung cancer cells | |
A case of pulmonary capillary hemangiomatosis presented as recurrent pneumothorax | |
Triptolide potentiates pemetrexed-induced lung cancer cell death via heat shock protein 70 inhibition | |
Pemetrexed continuation maintenance versus conventional platinum-based doublet chemotherapy in EGFR-negative lung adenocarcinoma: retrospective analysis | |
A case of AL amyloidosis mimicking lymphoproliferative disease | |
재발성 기흉으로 내원하여 진단된 Birt-Hogg-Dub? 증후군 1예 | |
EGFR 돌연변이 양성 폐선암에서 아파티닙 치료 후 편평세포암으로의 조직형 변환 및 T790M 돌연변이가 동시 발견된 1 예 | |
Isocyanate에 의한 과민성 폐렴 및 직업성 천식 동시 발생 1례 | |
Positive PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with EGFR-TKIs | |
Deep vein thrombosis, pulmonary thromboembolism, aortic vegetation and stroke in advanced lung adenocarcinoma: A case of Trousseau’s syndrome | |
TAS-116, a Novel Heat Shock Protein 90 Inhibitor, Enhances Radiosensitivity of Lung Cancer Cells | |
Clinical Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma | |
Clinical Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma | |
A case of diffuse alveolar hemorrhage after illegal vaginal injection of hyaluronic acid | |
Total lymphocyte count and neutrophil-to-lymphocyte ratio as prognostic markers in patients with small cell lung cancer | |
전이성 폐선암 환자에서 pembrolizumab치료 중 발생한 근염 1 예 | |
비디오 흉강경으로 진단된 급성 섬유소성 기질화 폐렴 1 예 | |
A case of pulmonary sclerosing pneumocytoma with multiple lung and bone metastasis | |
경피적 바늘 폐생검 조직에서 폐선암과 폐결핵이 동시 진단된 1례 | |
In-depth proteomic analysis of human bronchoalveolar lavage fluid towards the biomarker discovery for lung cancers | |
Radiosensitizing effect of combined triptolide and irradiation treatment in lung cancer cell lines | |
Positive PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with EGFR-TKIs | |
A case of pulmonary sclerosing pneumocytoma with multiple lung and bone metastasis | |
Isocyanate-induced hypersensitivity pneumonitis and coexistence of occupational asthma | |
Prolonged response to pembrolizumab in a patient with pulmonary sarcomatoid carcinoma | |
A case of mediastinal and pleural lipomatosis in a patient with seropositive rheumatoid arthritis | |
Unfavorable Outcome to Pembrolizumab in Lung Adenocarcinoma with High PD-L1 and STK11/KRAS co-mutations | |
Long-term efficacy of afatinib in lung adenocarcinoma harboring an EGFR exon 20 insertion | |
A Case of Desmoid Tumor Mimicking Pleural Recurrence after Curative Resection of Lung Adenocarcinoma | |
만성골수세포백혈병으로 다사티닙 복용 중 발생한 유미흉 1예 | |
Triptolide enhances radiosensitivity of lung cancer cells via G2/M arrest and autophage | |
High PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with targeted therapy | |
A Case of Mediastinal and Pleural Lipomatosis in a Patient with Seropositive Rheumatoid Arthritis | |
Diagnostic and Predictive Values of 18F-FDG PET/ CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma | |
Primary Resistance to Immune Checkpoint Blockade in an STK11/TP53/KRAS-Mutant Lung Adenocarcinoma with High PD-L1 Expression |
호흡기·알레르기내과 이승현 교수 - '2023 아시아 태평양 호흡기 학술대회'에서 연구 결과 발표
2023-11-23
호흡기·알레르기내과 이승현 교수 - 폐암, 골격계 합병증 예방의 중요성...뼈전이 치료에 효율적인 약물 엑스지바
2023-06-21
호흡기·알레르기내과 이승현 교수 - "폐암 항암제, 희귀 유전자돌연변이 급여 보장 우선"
2023-05-22
호흡기·알레르기내과 이승현 교수 - 소세포폐암의 잠재적인 바이오마커 후보군 찾았다
2023-03-10
호흡기·알레르기내과 이승현 교수 - 폐암
2023-01-27
호흡기·알레르기내과 이승현 교수 - ""미세먼지, 요리 매연… 일상의 유해물질들이 폐암 유발""
2023-01-11
호흡기·알레르기내과 이승현 교수 - “폐암, 4기여도 적극적으로 치료 받으면 생존율 증가”
2023-01-10
호흡기·알레르기내과 이승현 교수 - 사망률 1위 폐암, 검진은 엑스레이로 충분할까?
2022-12-23
호흡기·알레르기내과 이승현 교수 - 국내 암 발병 2위 ‘폐암’, 생존율 높이기 위한 맞춤 치료
2022-12-19
호흡기·알레르기내과 이승현 교수 - 말기암 환자 살린 ‘NGS’…“발병 초기부터 유전자 검사 필요”
2022-11-18
호흡기알레르기내과 이승현 교수 - 침묵의 살인자 ‘폐암’ 조기 발견 위해 알아야 팁
2022-10-25
호흡기·알레르기내과 이승현 교수 - 폐암 조기 진단키트 임상시험 책임자로 참여
2022-10-13
호흡기·알레르기내과 이승현, 병리과 성지연 교수 - ‘종양변이부담' 통해 폐암 표적치료제 효과 예측
2022-09-19
호흡기·알레르기내과 이승현 교수 - 타브렉타의 빠른 급여화 통해 환자들에게 보다 좋은 치료 제공되어야
2022-08-02
호흡기·알레르기내과 이승현 교수 - 타브렉타의 빠른 급여를 통해 유전자 변이 폐암 환자 치료해야
2022-06-28
이비인후과 이승현 교수 - 고의의학상 수상
2022-01-20
호흡기·알레르기내과 이승현 교수 - 고의의학상 수상
2022-01-19
감사와 응원의 메시지를 전해주세요.
나도 작성하기준비중입니다.
잠시만 기다려주시기 바랍니다.